Positive predictive value highlights four novel candidates for actionable genetic screening from analysis of 220,000 clinicogenomic records
Author:
Publisher
Elsevier BV
Subject
Genetics (clinical)
Link
https://www.nature.com/articles/s41436-021-01293-9.pdf
Reference40 articles.
1. Centers for Disease Control and Prevention. Tier 1 genomics applications and their importance to public health. 2019. https://www.cdc.gov/genomics/implementation/toolkit/tier1.htm.
2. Murray MF et al. DNA-based screening and population health: a points to consider statement for programs and sponsoring organizations from the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23:989–995 https://doi.org/10.1038/s41436-020-01082-w.
3. Miller DT, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021. https://doi.org/10.1038/s41436-021-01172-3.
4. Clinical outcomes of a genomic screening program for actionable genetic conditions;Buchanan,2020
5. Association of rare pathogenic DNA variants for familial hypercholesterolemia, hereditary breast and ovarian cancer syndrome, and Lynch syndrome with disease risk in adults according to family history;Patel,2020
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exome sequencing identifies novel genetic variants associated with varicose veins;PLOS Genetics;2024-07-09
2. A power-based sliding window approach to evaluate the clinical impact of rare genetic variants in the nucleotide sequence or the spatial position of the folded protein;Human Genetics and Genomics Advances;2024-07
3. Combining rare and common genetic variants improves population risk stratification for breast cancer;Genetics in Medicine Open;2024
4. Patients with Type 2 Diabetes and aGCKvariant are still at risk for T2D-related secondary complications;2023-12-19
5. Combined population genomic screening for three high-risk conditions in Australia: a modelling study;eClinicalMedicine;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3